What is MGF / PEG-MGF?

MGF (Mechano Growth Factor), also called IGF-1Ec, is a splice variant of IGF-1 produced in muscle in response to mechanical stress. PEG-MGF is a pegylated form modified in research settings to extend its half-life. Both are growth-factor compounds.

What does research suggest MGF does?

Mechanistic and animal studies discuss a role for MGF in activating muscle satellite cells and supporting muscle repair signalling. Human evidence is minimal and largely anecdotal, so these findings remain preclinical and unproven in people.

Is MGF / PEG-MGF approved or legal?

No. MGF and PEG-MGF are not approved medicines in major jurisdictions and circulate under research-chemical status. They are also prohibited in sport under anti-doping regulations.

Is MGF safe, and what are the potential side effects?

The long-term safety profile in humans is unknown. As a growth-factor signalling compound it carries theoretical class risks, and unregulated research-market material has unverified purity and identity. There is no established human safety data.

How is MGF different from IGF-1 or IGF-1 LR3?

MGF is a specific splice variant of IGF-1 associated with local muscle response to loading, whereas IGF-1 LR3 is a modified long-acting IGF-1 analogue. All act on IGF-related growth pathways but differ in structure and half-life, and none are validated therapies in this form.

Is there human clinical evidence for MGF?

Human clinical evidence is minimal. There are no robust controlled trials establishing benefit or safety of administered MGF or PEG-MGF; most support is mechanistic, animal-based, or anecdotal.

How is MGF related to IGF-1, and why the different name?

MGF is not a separate hormone but a splice variant of the IGF-1 gene, corresponding to the IGF-1Ec isoform. The name Mechano Growth Factor reflects that this variant was first identified in muscle subjected to mechanical loading. Because it shares the IGF-1 backbone, discussion of MGF overlaps heavily with the broader IGF-1 pathway rather than describing a wholly distinct molecule.

What is the difference between MGF and PEG-MGF?

PEG-MGF is a pegylated version, meaning polyethylene glycol chains are attached to the peptide. Pegylation is a common technique intended to slow breakdown and clearance, so PEG-MGF is generally discussed as a longer-lasting form than unmodified MGF. This is a chemistry distinction described in research-market materials, not a claim about proven benefit in humans, for which evidence is minimal.

Why is MGF popular in fitness circles despite weak evidence?

Its appeal comes largely from the plausible-sounding biology: because MGF is tied to how muscle responds to loading and to satellite-cell activation, it is marketed as a recovery aid. That mechanistic story, however, comes mostly from animal and cell studies. The gap between an interesting laboratory signal and a demonstrated, safe human effect is exactly what remains unfilled here, which is a common pattern with growth-factor research chemicals.

Where can I buy MGF / PEG-MGF and compare vendors?

Use the vendor comparison on this page. It shows only checked, product-specific links and identifies vendor claims, independent documentation and affiliate relationships separately. Availability and legal status can vary by country.

Growth Factor

Buy MGF / PEG-MGF – Vendors, Prices, Testing and Evidence

Buy MGF / PEG-MGF

Also known as: Mechano Growth Factor · IGF-1Ec

Evidence grade D — AnecdotalRisk flag

Short answer

A splice variant of IGF-1 discussed for muscle repair. Human evidence is minimal.

Where can you buy MGF / PEG-MGF?

Crystal Peptides. The table lists only product-specific offers that were checked and for which a real destination exists. Missing prices, quantities, stock and laboratory details are not inferred.

What is known?

MGF is a mechano-growth-factor splice variant of IGF-1; PEG-MGF is a pegylated form.

What is not established?

Minimal; largely mechanistic and anecdotal.

Safety

Growth-factor signalling carries theoretical risks; unverified research-market material.

Regulatory status

Not an approved medicine. Research chemical status; prohibited in sport.

Not medical advice. This educational reference is not diagnosis, treatment, prescribing, dosing or emergency guidance. Consult a qualified professional before making health-related decisions.

Regulatory or safety concern: This substance may be unapproved for human use, affect the hormonal system, or be subject to regulator or anti-doping restrictions. Check the cited evidence and rules in your jurisdiction.

Vendor comparison

Buy MGF / PEG-MGF: compare vendors

The table lists only product-specific offers that were checked and for which a real destination exists. Missing prices, quantities, stock and laboratory details are not inferred.

Vendor	Product	Documentation	Shipping	Checked	Action
Crystal Peptides Code PEPTIDES10 −10% · discount code details Sponsored	MGF / PEG-MGF research product	Vendor-supplied data COA stated as available Not independently documented	Europe See the localized country store	Jul 18, 2026	View at vendor

Crystal Peptides

MGF / PEG-MGF research product

Code PEPTIDES10 −10% · discount code details

What is it?

MGF is a mechano-growth-factor splice variant of IGF-1; PEG-MGF is a pegylated form.

Research and evidence

MGF, short for Mechano Growth Factor, is a splice variant of insulin-like growth factor 1 (IGF-1), sometimes written as IGF-1Ec. It is produced locally in muscle tissue in response to mechanical loading and damage, and in scientific literature it has been discussed for its possible role in activating satellite cells, the muscle stem cells involved in repair and regeneration. PEG-MGF is a pegylated (polyethylene-glycol-attached) form engineered in a research context to resist rapid breakdown and extend the molecule's half-life. Both belong to the broader growth-factor category and are frequently grouped alongside IGF-1 analogues in peptide discussions.

MGF and PEG-MGF are studied and discussed primarily because of the underlying biology of local IGF-1 signalling in muscle: the natural MGF splice variant appears in animal and cell-based work to be part of how muscle responds to exercise and injury. That mechanistic interest is why the compound circulates in fitness and research communities. However, the honest evidence picture is limited. Human clinical evidence for MGF or PEG-MGF as administered products is minimal and largely mechanistic or anecdotal, with no controlled trials establishing meaningful benefit or safety in people. Animal studies report some muscle-repair signalling effects, but these are preclinical and do not translate directly to human outcomes. Its assigned evidence tier reflects how thin and indirect the data are.

Regulatory and safety status should be understood plainly. MGF / PEG-MGF is not an approved medicine in any major jurisdiction; material in circulation carries a research-chemical designation, is unregulated for purity or identity, and is prohibited in sport under anti-doping rules. Because it acts on growth-factor signalling pathways, there are theoretical concerns common to this class, and the long-term safety profile in humans is unknown. This page is an educational reference summarizing what MGF is and what research does and does not show; it is not medical advice and does not endorse use.

Evidence grade: D

Minimal; largely mechanistic and anecdotal. Some muscle-repair signalling reported.

Human evidence

Minimal; largely mechanistic and anecdotal.

Animal and preclinical evidence

Some muscle-repair signalling reported.

Proposed mechanisms

Discussed roles in muscle satellite-cell activation

Safety concerns and known side effects

Growth-factor signalling carries theoretical risks; unverified research-market material.

Unknown long-term profile

Regulatory status

Not an approved medicine. Research chemical status; prohibited in sport.

MGF / PEG-MGF research timeline

1990s
Researchers studying mechanically loaded muscle describe an alternatively spliced variant of IGF-1 and name it Mechano Growth Factor (MGF), corresponding to the human IGF-1Ec isoform.
1990s-2000s
Preclinical rodent and cell-culture studies explore MGF's proposed role in activating muscle satellite cells and supporting repair after mechanical stress, establishing it as a mechanistic research interest rather than a therapy.
2000s
Investigators examine synthetic MGF peptides and the distinct signalling of the E-domain peptide, but studies remain small, mechanistic, and largely confined to animal and in-vitro models.
Late 2000s-2010s
A pegylated form marketed as PEG-MGF appears in the research-chemical and bodybuilding markets, promoted for muscle recovery despite no clinical development program and no human efficacy data.
2010s-present
Anti-doping authorities classify muscle-affecting growth factors as prohibited in sport at all times, and MGF-type peptides remain unapproved research chemicals with no regulatory approval as medicines.

Frequently asked questions about MGF / PEG-MGF

What is MGF / PEG-MGF?: MGF (Mechano Growth Factor), also called IGF-1Ec, is a splice variant of IGF-1 produced in muscle in response to mechanical stress. PEG-MGF is a pegylated form modified in research settings to extend its half-life. Both are growth-factor compounds.
What does research suggest MGF does?: Mechanistic and animal studies discuss a role for MGF in activating muscle satellite cells and supporting muscle repair signalling. Human evidence is minimal and largely anecdotal, so these findings remain preclinical and unproven in people.
Is MGF / PEG-MGF approved or legal?: No. MGF and PEG-MGF are not approved medicines in major jurisdictions and circulate under research-chemical status. They are also prohibited in sport under anti-doping regulations.
Is MGF safe, and what are the potential side effects?: The long-term safety profile in humans is unknown. As a growth-factor signalling compound it carries theoretical class risks, and unregulated research-market material has unverified purity and identity. There is no established human safety data.
How is MGF different from IGF-1 or IGF-1 LR3?: MGF is a specific splice variant of IGF-1 associated with local muscle response to loading, whereas IGF-1 LR3 is a modified long-acting IGF-1 analogue. All act on IGF-related growth pathways but differ in structure and half-life, and none are validated therapies in this form.
Is there human clinical evidence for MGF?: Human clinical evidence is minimal. There are no robust controlled trials establishing benefit or safety of administered MGF or PEG-MGF; most support is mechanistic, animal-based, or anecdotal.
How is MGF related to IGF-1, and why the different name?: MGF is not a separate hormone but a splice variant of the IGF-1 gene, corresponding to the IGF-1Ec isoform. The name Mechano Growth Factor reflects that this variant was first identified in muscle subjected to mechanical loading. Because it shares the IGF-1 backbone, discussion of MGF overlaps heavily with the broader IGF-1 pathway rather than describing a wholly distinct molecule.
What is the difference between MGF and PEG-MGF?: PEG-MGF is a pegylated version, meaning polyethylene glycol chains are attached to the peptide. Pegylation is a common technique intended to slow breakdown and clearance, so PEG-MGF is generally discussed as a longer-lasting form than unmodified MGF. This is a chemistry distinction described in research-market materials, not a claim about proven benefit in humans, for which evidence is minimal.
Why is MGF popular in fitness circles despite weak evidence?: Its appeal comes largely from the plausible-sounding biology: because MGF is tied to how muscle responds to loading and to satellite-cell activation, it is marketed as a recovery aid. That mechanistic story, however, comes mostly from animal and cell studies. The gap between an interesting laboratory signal and a demonstrated, safe human effect is exactly what remains unfilled here, which is a common pattern with growth-factor research chemicals.
Where can I buy MGF / PEG-MGF and compare vendors?: Use the vendor comparison on this page. It shows only checked, product-specific links and identifies vendor claims, independent documentation and affiliate relationships separately. Availability and legal status can vary by country.

Common discussion areas

Muscle repairIGF pathway

Compare MGF / PEG-MGF

MGF / PEG-MGF vs IGF-1 LR3

Sources

Editorial review and transparency

Written by: peptides.cx Editorial Team
Scientific reviewer: No named medical reviewer is currently assigned
Last editorial review: June 1, 2026
Last vendor check: July 18, 2026
Review method: Source review, claim verification, vendor-data separation and regulatory-context review.
Commercial disclosure and conflicts: Vendor relationships do not determine evidence or safety ratings. No named reviewer conflict is recorded because no named reviewer is assigned.

Editorial policy →Evidence grade →Vendor methodology →

Related on peptides.cx

Library →Vendor quality checklist →Safety →Affiliate code: PEPTIDES10